4-(((3,3-Dimethylbutan-2-yl)amino)methyl)benzoic acid, 98%, 500mg

(R)-1-(Pyridin-3-ylmethyl)-3-(pyrrolidin-3-yl)urea hydrochloride, 1g

(2S,3R,4S,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)-2-METHOXYTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL, 95%, 100g

(2E)-3-(4-oxo-4H-chromen-3-yl)acrylic acid, 95.0%, 250mg

Óxido de níquel(II), mínimo 75 % Ni, pa, negro, malla 400, 500 g, envase de plástico.

2-(Piperazin-1-yl)phenol hydrochloride, 97.0%, 100g

6,7-DIFLUOROQUINOLIN-3-AMINE, 95.0%, 1g

6-O-Benzyl 2-O-tert-butyl 10-oxo-2,6,9-triazaspiro[4.5]decane-2,6-dicarboxylate, 97%, 250mg

7-fluoro-1-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one, 98%, 100mg

ROTI®Quant, 500 ml, 2000 ensayos (cubetas)

2-(1-Iodoethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

(2,3-Dichlorophenyl)methanol, 95.0%, 10g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carbaldehyde, 98%, 1g